Keyword

laropiprant

Description: Laropiprant is a drug that selectively blocks the prostaglandin D2 DP1 receptor, investigated in pharmacological and clinical studies.
Wikidata ID: wiki/Q412291
OpenAlex ID: keywords/laropiprant
2014 · The HPS2-THRIVE Collaborative Group · New England Journal of Medicine · 1,780
2009 · V. S. Kamanna, S. H. Ganji, et al. · International Journal of Clinical Practice · 162
2007 · E Lai, I De Lepeleire, et al. · Clinical Pharmacology & Therapeutics · 156
2018 · Sarah Parish, Jemma C. Hopewell, et al. · Circulation Genomic and Precision Medicine · 102
2010 · Darbie Maccubbin, Diane Tipping, et al. · Clinical Journal of the American Society of Nephrology · 62
2013 · U. Julius, S. Fischer · Atherosclerosis Supplements · 60
2009 · George Philip, Janet van Adelsberg, et al. · Journal of Allergy and Clinical Immunology · 56
2007 · E Lai, LA Wenning, et al. · Clinical Pharmacology & Therapeutics · 48
2009 · Derek J Hausenloy, Derek M Yellon · Current Opinion in Cardiology · 46
2008 · Vaijinath S. Kamanna, Shobha H. Ganji, et al. · Current Atherosclerosis Reports · 42
2008 · H. E. Bays, D. J. Rader · International Journal of Clinical Practice · 42
2011 · Matilda Florentin, Evangelos N. Liberopoulos, et al. · Current Vascular Pharmacology · 40
2008 · Vaijinath S Kamanna, Anthony Vo, et al. · Current Opinion in Cardiology · 39
2010 · James McKenney, Harold Bays, et al. · Journal of clinical lipidology · 33
2014 · Madhumathi Rao, Michael Steffes, et al. · American Journal of Nephrology · 31
2009 · Harold E Bays, Christie Ballantyne · Current Opinion in Lipidology · 29
Works count: 206
Citation count: 4,899
Year
Topic
Type